Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · IEX Real-Time Price · USD

1.052

+0.002 (0.19%)

At close: May 2, 2024, 4:00 PM

1.010

-0.042 (-3.99%)

After-hours: May 2, 2024, 7:22 PM EDT

Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021
Market Capitalization	39	63	60	-
Market Cap Growth	-	5.34%	-	-
Enterprise Value	29	61	61	0
PE Ratio	-4.67	-5.70	-60.43	-
PB Ratio	4.26	-5.40	-26.68	-
P/FCF Ratio	-3.20	-47.46	-57.66	-
P/OCF Ratio	-3.20	-47.46	-57.66	-
EV/EBITDA Ratio	-3.59	-5.46	-66.25	-
EV/EBIT Ratio	-3.59	-5.46	-66.25	-0.23
EV/FCF Ratio	-2.46	-45.40	-58.10	-
Debt / Equity Ratio	-	-	-0.22	8.73
Debt / EBITDA Ratio	-	-	-0.54	-
Debt / FCF Ratio	-	-	-0.48	-
Quick Ratio	22.69	0.28	0.04	0.05
Current Ratio	23.69	0.28	0.05	0.06
Return on Equity (ROE)	1924.00%	177.20%	62.00%	-
Return on Assets (ROA)	-77.90%	-72.30%	-3.80%	-
Return on Capital (ROIC)	-92.43%	94.65%	89.33%	-365.70%
Earnings Yield	-21.72%	-17.53%	-1.65%	-
FCF Yield	-31.74%	-2.11%	-1.73%	-
Buyback Yield / Dilution	-510.82%	77.96%	-476.29%	-
Total Shareholder Return	-510.82%	77.96%	-476.29%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).